Preclinical studies of a vaccine for the prevention of cat allergy have begun in Russia. This was announced on April 22 by the head of the Department of Clinical Immunology and Allergology of the Sechenov University, Alexander Karaulov.
“We are ready now and have already begun … The first preclinical tests will be carried out rather quickly, the safety and efficacy of the obtained drug have been confirmed,” Karaulov told RIA Novosti.
The RAS academician noted that the research will be carried out quickly enough.
Researchers at Sechenov University, together with the Medical University of Vienna, are developing a vaccine. This year, scientists plan to complete preclinical studies of the vaccine and move on to clinical ones. If the trials are successful, we can expect to vaccinate clinical trial participants in the summer of 2022.
On April 19, the zoopsychologist Miroslav Volkov gave some advice to people wishing to have a pet in the studio of the Point of View program. Volkov noted that the choice of a pet should be taken soberly and factors such as the presence of allergies, the area of the apartment and the time a person is willing to devote to the animal should be evaluated.